(19)
(11)EP 3 482 639 B1

(12)EUROPEAN PATENT SPECIFICATION

(45)Mention of the grant of the patent:
22.07.2020 Bulletin 2020/30

(21)Application number: 18205570.7

(22)Date of filing:  05.11.2013
(51)International Patent Classification (IPC): 
A23K 20/10(2016.01)
A23K 20/158(2016.01)
A23K 20/24(2016.01)
A23K 50/40(2016.01)
A23K 20/147(2016.01)
A23K 20/22(2016.01)
A23K 20/26(2016.01)

(54)

PALATABILITY ENHANCERS FOR FOODS DESIGNED FOR DOGS AND CATS WITH RENAL INSUFFICIENCY

GESCHMACKSVERBESSERER FÜR NAHRUNGSMITTEL FÜR HUNDE UND KATZEN MIT NIERENINSUFFIZIENZ

EXHAUSTEURS DE GOÛT POUR ALIMENTS POUR CHIENS ET CHATS PRESENTANT UNE INSUFFICANCE RENALE


(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(43)Date of publication of application:
15.05.2019 Bulletin 2019/20

(62)Application number of the earlier application in accordance with Art. 76 EPC:
13792555.8 / 3065559

(73)Proprietor: Hill's Pet Nutrition, Inc.
Topeka, KS 66603 (US)

(72)Inventors:
  • JEWELL, Dennis, Edward
    Lawrence, KS Kansas 66049 (US)
  • VANCHINA, Melissa
    Piscataway, NJ 08854 (US)
  • VONDRAN, Jodi
    Wamego, KS Kansas 66547 (US)

(74)Representative: Wichmann, Hendrik 
Wuesthoff & Wuesthoff Patentanwälte PartG mbB Schweigerstraße 2
81541 München
81541 München (DE)


(56)References cited: : 
WO-A1-00/30456
WO-A1-2012/148769
US-A1- 2005 037 108
US-A1- 2006 141 011
WO-A1-2012/115648
WO-A2-2006/119049
US-A1- 2005 106 285
  
  • FINCO D R, BROWN S A, CROWELL W A, DUNCAN R J, BARSANTI J A, BENNETT S E: "Effects of dietary phosphorus and protein in dogs with chronic renal failure", AMERICAN JOURNAL OF VETERINARY RESEARCH, vol. 53, no. 12, 1 January 1992 (1992-01-01), pages 2264-2271, XP008170629,
  
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).


Description

Field



[0001] The present invention relates to pet food compositions comprising a palatability enhancing composition for use in ameliorating a symptom in a companion animal that is suffering from renal insufficiency or disease, whereby said pet food composition increases its consumption by the companion animal.

Background



[0002] It is known that cats with renal disease benefit from consuming foods that are restricted in phosphorus. See, e.g., "Survival of cats with naturally occurring chronic renal failure: effect of dietary management," J. Elliott et al.; Journal of Small Animal Practice Volume 41, Issue 6, pages 235-242, June 2000. It is also known that dietary protein and phosphorus restriction enhances quality and length of life in cats with renal failure. See "Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats," Sheri J. Ross, et al., Journal of the American Veterinary Medical Association September 15, 2006, Vol. 229, No. 6, Pages 949-957. Because a universal constant of renal disease is inappetence, there is a significant need for foods which are tasty and preferred by animails, for example cats and dogs, with renal disease. Thus there is a need for compositions and methods that enhance the palatability of pet foods for companion animals suffering from renal disease and insufficiency. This invention is directed to these, as well, as other, important ends.

[0003] US 2005/0037108 A1 discloses a palatability enhancing composition comprising tetrapotassium pyrophosphate for an animal feed, effective to enhance palatability of the food for healthy companion animals.

[0004] WO 2012/148769 A1 discloses a palatability enhancing composition comprising tetrasodium pyrophosphate (TSPP) and animal by-products and/or microbial proteins.

[0005] Finco et al. American Journal of Veterinary Research discloses effects of dietary phosphorous and protein in dogs with chronic renal failure.

[0006] US 2006/014011 A1 is directed to compositions for animal consumption that tend to improve kidney function, which exhibit reduced quantities of protein and/or phosphorus, and enhanced dietary antioxidants.

[0007] WO 2006/1190492 A2 discloses a method for prolonging feline life, suffering from renal disease, comprising feeding a food characterized by defined levels of protein, phosphorous, and sodium.

[0008] US 2005/0106285 A1 discloses a palatability enhancing composition containing at least one tripolyphosphate salt and animal by-products and/or microbial proteins.

[0009] WO 2012/115648 A1 is directed to biomarkers of a renal disease. Renal food compositions are not disclosed.

[0010] WO 00/30456 A1 discloses a palatability enhancer comprising tetrasodium pyrophosphate as a coating for a dry pet food.

Summary



[0011] Unless otherwise indicated, the terms "%" or "percent" when used in connection with an ingredient of the compositions of the invention is intended to refer to the percent by weight of the indicated ingredient in the composition.

[0012] Disclosed herein are palatability enhancing compositions for use in pet foods, where the palatability enhancing compositions include protein and phosphorus in a ratio of 5:1 to 15:1; such as less than 12:1; or 11:1, 10:1, 9:1, 8:1, 7:1, 6:1 or 5:1.

[0013] Further disclosed are pet foods containing a palatability enhancing composition as described above. The pet food compositions are designed for animals, e.g. companion animals, e.g. dogs and cats, suffering from renal insufficiency or disease.

[0014] In some embodiments, the palatability enhancing composition is present in the pet food composition in an amount of up to 10% by weight, or up to 5% by weight, or from 1% to 5% by weight, or from 1% to 4% by weight, or 1%, 2%, 3%, 4% or 5% by weight of the pet food composition.

[0015] The present invention provides a pet food composition that comprises a palatability enhancing composition of the invention as described above for use in ameliorating a symptom in a companion animalthat is suffering from a renal deficiency, as further defined in the claims.

Detailed Description



[0016] It has been discovered in accordance with the present invention that manipulation of the protein to phosphorus ratio of palatability enhancing compositions can result in a specific palatability enhancement effect on animals with renal deficiency. Specifically, maintaining a protein to phosphorus ratio of 5:1 to 15:1; such as less than 12:1; or 11:1, 10:1, 9:1, 8:1, 7:1 6:1 or 5:1 results in increased palatability specifically in animals with renal deficiency, e.g., cats and dogs, while not showing the same effect on healthy animals. Thus, the compositions described herein are especially beneficial for animals with renal deficiency, which tend to suffer from loss of appetite. While the palatability enhancer having a relatively high phosphorous level enhances consumption, the total phosphorous level can be kept a low level, as is desirable for these animals.

[0017] Accordingly, disclosed are palatability enhancing compositions for use in pet foods, where the palatability enhancing compositions include protein and phosphorus in a ratio of 5:1 to 15:1; such as less than 12:1; or 11:1, 10:1, 9:1, 8:1, 7:1 6:1 or 5:1; at least 5:1.

[0018] Typically, palatability enhancers are formulated to ensure that the whole food composition meets the nutritional needs of the target animal. By maintaining a specific range for the ratio of protein to phosphorus in the palatability enhancers, the palatability enhancer more precisely fits with the nutrient needs of the animal.

[0019] Disclosed are pet foods that contain a palatability enhancing composition as described above. The pet food composition is one that is designed for animals with renal insufficiency or disease.

[0020] Generally, the palatability enhancing composition is present in the pet food composition in an amount effective to enhance palatability. In some embodiments, the palatability enhancing composition is present in the pet food composition in an amount of up to 10% by weight, or up to 5% by weight, or from 1% to 5% by weight, or from 1% to 4% by weight, or 1%, 2%, 3%, 4% or 5% by weight of the pet food composition.

[0021] The palatability enhancing compositions can be added to the pet food composition by a variety of means known in the art, including for example by coating the pet food (e.g., a pet food kibble) with a palatability enhancing compositiondescribed herein. For example, in one embodiment, the palatability enhancer is applied to particles or pieces of extruded, dry or semi-dry cat food. Alternatively, the palatability enhancing composition can be incorporated into the pet food (or example an extruded pet food) during production. Accordingly, further disclosed are methods for enhancing the palatability of the pet food composition, comprising the step of treating the pet food composition to include a palatability enhancing composition as described herein. As used herein, "treating the pet food composition" is intended to include any manner of adding or incorporating the palatability enhancing compositions of the present disclosure into or on the surface of the pet food composition.

[0022] The present invention provides a pet food composition that comprises a palatability enhancing composition as described above for use in ameliorating a symptom in a companion animal; suffering from a renal deficiency, as further defined in the claims.

[0023] The palatability enhancers can be used with a wide variety of pet foods to increase palatability. Such compositions are not intended to be limited to a specific listing of ingredients because such ingredients will depend on such factors as, for example, the desired nutritional balance for the specific type of pet, and availability of ingredients to the manufacturer. In addition to the proteinaceous and farinaceous materials, the pet food composition generally may include vitamins, minerals, and other additives such as flavorings, preservatives, emulsifiers and humectants. The nutritional balance, including the relative proportions of vitamins, minerals, fat, protein and carbohydrate, is determined according to dietary standards known in the veterinary art. For example, the nutritional balance of a cat food composition is determined according to the known dietary requirements for cats.

[0024] The pet food is one that is designed for animals with renal insufficiency or disease. Such foods are known in the art to have restricted amounts of protein and phosphorus relative to foods designed for healthy animals. For example, pet food compositions designed for animals with renal insufficiency or disease may typically contain approximately 25%-30% protein, whereas foods for healthy animals typically contain 30%-50% protein. Therefore, the amount of palatability enhancer added to the food preferably does not increase amounts of protein and phosphorus to levels above those levels suitable for animals with renal insufficiency or disease.

[0025] The palatability enhancers improve the palatability of wet, dry and semi-dry pet foods, and are particularly suitable for dry and semi-dry cat foods.

[0026] The disclosure describes a palatability enhancer (Enhancer 1) comprising a protein to phosphorus ratio of 5:1 to 15:1; such as less than 12:1; or 11:1, 10:1, 9:1, 8:1, 7:1 6:1 or 5:1, and at least 5:1. For example,

1.1. Enhancer 1 wherein the protein to phosphorous ratio is between 5:1 and 15:1, e.g., from 10:1 to 12:1.

1.2. Enhancer 1 comprising:

from 38% to 47% protein;

from 5% to 8% fat;

up to 0.5% crude fiber;

from 15% to 27% ash; and

from 4% to 6% phosphorus.



[0027] The disclosure further provides a pet food composition (Composition 1) comprising a palatability enhancing amount of a palatability enhancer selected from Enhancer 1, et seq. for example:

1.1. Composition 1 wherein the composition is designed for animals, for example companion animals, suffering from renal insufficiency or disease.

1.2. Composition 1 or 1.1 wherein the composition is palatable and nutritionally complete for a cat or a dog.

1.3. Any foregoing composition which is a wet, dry or semi-dry food.

1.4. Any foregoing composition wherein the palatability enhancer has been applied to the surface of a dry or semi-dry food.

1.5. Any foregoing composition wherein the palatability enhancer is present in an amount effective to enhance palatability, for example up to 10% by weight, or up to 5% by weight, or from 1% to 10, e.g., % 1% to 5% by weight, or from 1% to 4% by weight, or 1%, 2%, 3%, 4% or 5% by weight of the pet food composition.

1.6. Any foregoing composition wherein the pet food composition is designed for cats with renal insufficiency or disease.

1.7. Any foregoing composition wherein the pet food composition is designed for dogs with renal insufficiency or disease.

1.8. Any foregoing composition where the palatability enhancer comprises:

from 38% to 47% protein;

from 5% to 8% fat;

up to 0.5% crude fiber;

from 15% to 27% ash; and

from 4% to 6% phosphorus.

1.9. Any foregoing composition, which is palatable and nutritionally complete for a cat.

1.10. Any foregoing composition, which is feline diet comprising, on a dry matter basis:

Protein 25-35%

Fat 15-30%

Crude Fiber 1-10%

Calcium 0.45 - 1.0%

Phosphorus 0.35 - 0.70%

Sodium 0.2 - 1.0 %

Potassium 0.5 - 1.0 %

1.11. Any foregoing composition, which is a feline diet comprising the following components, in approximately (e.g., ± 5%) the following amounts by weight on a dry matter basis:

Protein 27.9%

Fat 20.3%

Crude Fiber 1.9%

Calcium 0.70%

Phosphorus 0.49%

Sodium 0.24%

Potassium 0.76%



[0028] The invention provides a pet food composition (Composition 1) comprising a palatability enhancing amount of a palatability enhancer (Enhancer 1) for use in ameliorating a symptom in a companion animal that is suffering from a renal deficiency or disease, as further defined in the claims.

[0029] Specifically, the invention provides a pet food composition (Composition 1) comprising a palatability enhancing amount of a palatability enhancer (Enhancer 1) for use in increasing food consumption of a companion animal that is suffering from a renal deficiency or disease, as further defined in the claims.

[0030] The following examples are further illustrative of the nature of the present invention, but it is understood that the invention is not limited thereto. All amounts and proportions referred to herein and in the appended claims are by weight, unless otherwise indicated.

Example 1 - Preparation and Testing of Pet Food Palatability Enhancer



[0031] A standard cat food palatability enhancer (Standard) having a phosphorus to protein ratio of 24.7 is compared to a palatability enhancer in accordance with the present invention (Test) having a phosphorus to protein ratio of 11.4. The palatability enhancers had the following compositions:
EnhancerTestStandard
Nutrientg/100 gg/100 g
Moisture 7.49 3.00
Protein 42.08 34.00
Fat 6.67 7.11
Crude Fiber 0.20 0.54
Ash 21.52 39.93
Phosphorus 4.79 8.40
Phosphorus to Protein (%) 11.4 24.7


[0032] The palatability enhancers are used in the same food at levels which provided equal palatability in normal cats. There are also no significant differences in the nutrient content of the two foods, with the food with the standard palatability enhancer containing 28.0% protein and 0.48% phosphorus while the food with the palatability enhancer according to the present disclosure contained 28.0% protein and 0.51% phosphorus (nutrient concentrations on a dry matter basis).

[0033] Intake ratios are considered measurements of palatability and food preference. Intake ratio is calculated by the following equation: (Test Food Consumed)/(Test Food Consumed+Standard Food Consumed). Thus, an intake ratio of 0.50 indicates that there is no preference between the two foods, while ratios which are statistically greater than 0.5 show that there is a significant preference for the test food. When the palatants are fed to normal healthy animals there is equal palatability in the two foods as shown by an intake ratio of 0.46 (test food/(test+standard)) with the standard food having a slightly higher intake ratio and with 46% of the cats preferring the food with the test palatant. When cats with renal insufficiency are given the same foods the intake ratio is significantly higher than 0.5 - specifically at 0.68, with 75% of the cats preferring the food with the test palatant.

[0034] The results show that the composition for use of the invention is specifically preferred by cats with renal insufficiency, and not preferred by normal cats.


Claims

1. A pet food composition comprising a palatability enhancing amount of a palatability enhancing composition, for use in ameliorating a symptom in a companion animal that is suffering from renal insufficiency or disease; characterized in that
the palatability enhancing composition comprises protein to phosphorus in a ratio of from 5:1 to 15:1, and
wherein the pet food composition increases consumption of the pet food composition by the companion animal.
 
2. The pet food composition for use according to claim 1, wherein the palatability enhancing composition is present in the pet food composition in an amount of 1% to 10% by weight.
 
3. The pet food composition for use according to claim 1, wherein the pet food composition is designed for animals, for example companion animals, suffering from renal insufficiency or disease.
 
4. The pet food composition for use according to any preceding claim, wherein the palatability enhancing composition comprises:

from 38% to 47% protein;

from 5% to 8% fat;

up to 0.5% crude fiber;

from 15% to 27% ash; and

from 4% to 6% phosphorus.


 
5. The pet food composition for use according to any preceding claim, which is palatable and nutritionally complete for a dog.
 
6. The pet food composition for use according to claims 1-4, which is palatable and nutritionally complete for a cat.
 
7. The pet food composition for use according to claim 5 or 6 which comprises, on a dry matter basis:

Protein 25-35%

Fat 15-30%

Crude Fiber 1-10%

Calcium 0.45 - 1.0%

Phosphorus 0.35 - 0.70%

Sodium 0.2 - 1.0 %

Potassium 0.5 - 1.0 %


 


Ansprüche

1. Haustierfutterzusammensetzung, die eine geschmacksverstärkende Menge einer geschmacksverstärkenden Zusammensetzung umfasst, zur Verwendung bei der Linderung eines Symptoms eines Haustiers, das an Niereninsuffizienz oder - erkrankung leidet, dadurch charakterisiert, dass
die geschmacksverstärkende Zusammensetzung Protein zu Phosphor in einem Verhältnis von 5:1 bis 15:1 umfasst, und
wobei die Haustierfutterzusammensetzung den Konsum der Haustierfutterzusammensetzung durch das Haustier erhöht.
 
2. Haustierfutterzusammensetzung zur Verwendung nach Anspruch 1, wobei die geschmacksverstärkende Zusammensetzung in der Haustierfutterzusammensetzung in einer Menge von 1% bis 10% bezogen auf das Gewicht vorliegt.
 
3. Haustierfutterzusammensetzung zur Verwendung nach Anspruch 1, wobei die Haustierfutterzusammensetzung für Tiere, beispielsweise Haustiere, die an Niereninsuffizienz oder -erkrankung leiden, konzipiert ist.
 
4. Haustierfutterzusammensetzung zur Verwendung nach einem der vorhergehenden Ansprüche, wobei die geschmacksverstärkende Zusammensetzung umfasst:

von 38% bis 47% Protein;

von 5% bis 8% Fett;

bis zu 0,5% Rohfaser;

von 15% bis 27% Asche; und

von 4% bis 6% Phosphor.


 
5. Haustierfutterzusammensetzung zur Verwendung nach einem der vorhergehenden Ansprüche, die für einen Hund schmackhaft und ernährungstechnisch vollwertig ist.
 
6. Haustierfutterzusammensetzung zur Verwendung nach Ansprüchen 1-4, die für eine Katze schmackhaft und ernährungstechnisch vollwertig ist.
 
7. Haustierfutterzusammensetzung zur Verwendung nach Anspruch 5 oder 6, die auf Trockenmassebasis umfasst:

Protein 25-35%

Fett 15-30%

Rohfaser 1-10%

Calcium 0,45 - 1,0%

Phosphor 0,35 - 0,70%

Natrium 0,2 - 1,0%

Kalium 0,5 - 1,0%.


 


Revendications

1. Composition alimentaire pour animaux de compagnie comprenant une quantité améliorant l'appétence d'une composition améliorant l'appétence, pour une utilisation dans l'amélioration d'un symptôme chez un animal de compagnie souffrant d'insuffisance rénale ou d'une néphropathie ; caractérisée en ce que
la composition améliorant l'appétence comprend des protéines par rapport au phosphore dans un rapport de 5:1 à 15:1, et
dans laquelle la composition alimentaire pour animaux de compagnie augmente la consommation de la composition alimentaire pour animaux de compagnie par l'animal de compagnie.
 
2. Composition alimentaire pour animaux de compagnie pour une utilisation selon la revendication 1, dans laquelle la composition améliorant l'appétence est présente dans la composition alimentaire pour animaux de compagnie en une quantité de 1 % à 10 % en poids.
 
3. Composition alimentaire pour animaux de compagnie pour une utilisation selon la revendication 1, dans laquelle la composition alimentaire pour animaux de compagnie est conçue pour des animaux, par exemple des animaux de compagnie, souffrant d'insuffisance rénale ou d'une néphropathie.
 
4. Composition alimentaire pour animaux de compagnie pour une utilisation selon l'une quelconque des revendications précédentes, dans laquelle la composition améliorant l'appétence comprend :

de 38 % à 47 % de protéines ;

de 5 % à 8 % de matières grasses ;

jusqu'à 0,5 % de fibres brutes ;

de 15 % à 27 % de cendres ; et

de 4 % à 6 % de phosphore.


 
5. Composition alimentaire pour animaux de compagnie pour une utilisation selon l'une quelconque des revendications précédentes, qui est appétente et complète sur le plan nutritionnel pour un chien.
 
6. Composition alimentaire pour animaux de compagnie pour une utilisation selon les revendications 1 à 4, qui est appétente et complète sur le plan nutritionnel pour un chat.
 
7. Composition alimentaire pour animaux de compagnie pour une utilisation selon la revendication 5 ou 6, qui comprend, sur une base de matière sèche :

protéines 25 à 35 %

matières grasses 15 à 30 %

fibres brutes 1 à 10 %

calcium 0,45 à 1,0 %

phosphore 0,35 à 0,70 %

sodium 0,2 à 1,0 %

potassium 0,5 à 1,0 %.


 






Cited references

REFERENCES CITED IN THE DESCRIPTION



This list of references cited by the applicant is for the reader's convenience only. It does not form part of the European patent document. Even though great care has been taken in compiling the references, errors or omissions cannot be excluded and the EPO disclaims all liability in this regard.

Patent documents cited in the description




Non-patent literature cited in the description